fbpx AstraZeneca Covid vaccine study results clouded by manufacturing error | mainlynews.gr

AstraZeneca Covid vaccine study results clouded by manufacturing error

LONDON — AstraZeneca and Oxford University on Wednesday acknowledged a manufacturing error that has raised questions about their Covid-19 vaccine after revealing earlier this week it was “highly effective” against the disease. On Monday, researchers said AstraZeneca vaccine had an efficacy of up to 90 percent when half a dose was administered followed by a full dose. That efficacy rate is on par with other vaccine candidates announced by Pfizer and Moderna earlier this month. In the group that got two full doses, the vaccine appeared to be 62 percent effective. Combined, the drugmakers said the vaccine appeared to be 70 ...

Δείτε επίσης

As at other hospitals, time took on a different dimension in 2-North, the designated COVID-19 unit at the West Roxbury VA for cases that require observation but don’t currently merit intensive care intervention.


Doubts have been raised about lifting Covid restrictions in the spring. What are the hurdles in the way?


Emerging evidence suggests the variant that emerged in the UK may be more deadly as well as spread faster.


This is additional taxonomy that helps us with analytics


Doctors say people should buy a pulse oximeter to monitor their oxygen levels at home.


Hopefully one day, getting vaccinated will mean you no longer need a mask. But not yet.


Even though kids rarely get very ill from COVID-19, vaccinating them will likely be key to reaching herd immunity.


Israel is likely to be the first country to see an impact from vaccination - but it is still too early.